$260.72
▲ $26.60 (+11.4%)
CRL
Charles River Laboratories
Health Care
Investor Score
56C
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
79
Technical
35
Fundamental
32
Growth
50
Fair Value
100
News
47
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.